Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Age verification legislation, H.R. 3149, App Store Accountability Act
Age verification legislation, H.R. 3149, App Store Accountability Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Research, development, and reimbursement of novel serotonergic agonists for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Source: Senate LDA
| ANTOFAGASTA MINERALS S.A. |
| 6 |
| 2024–2025 |
| COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) | 6 | 2024–2025 |
| EDIBLE BRANDS, LLC | 4 | 2026 |
| RECONVIEW, LLC | 4 | 2026 |
| VETERAN MENTAL HEALTH LEADERSHIP COALITION | 4 | 2026 |
| NAVA PBC | 3 | 2025 |
| CARLYLE INVESTMENT MANAGEMENT, LLC | 2 | 2025 |
| COMCAST CORPORATION | 2 | 2025 |
| PALL CORPORATION | 2 | 2026 |
| LITE RUN | 1 | 2024 |
| TOYOTA MOTOR NORTH AMERICA, INC. | 1 | 2025 |
Age verification legislation, H.R. 3149, App Store Accountability Act
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346) & federal funding for psychedelic medicine research
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346) & federal funding for psychedelic medicine research
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Freedom to Heal Act of 2025
Client: VETERAN MENTAL HEALTH LEADERSHIP COALITION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to H.R. 1 implementation and government contracting
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to H.R. 1 implementation and government contracting
Enhancing Energy Recovery Act
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Enhancing Energy Recovery Act
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Enhancing Energy Recovery Act
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act
Women’s Protection in Telehealth Act
Client: GRINDR, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Draft age verification legislation; S.1586/H.R.1349 - App Store Accountability Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
Primacy Certainty Act of 2025
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Primacy Certainty Act of 2025
Client: HEIMDAL, INC. · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Freedom to Heal Act of 2025
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Freedom to Heal Act (H.R.6434/S.3346)
Issues related to the implementation of the Inflation Reduction Act; issues related to tax policy; issues related to privacy policy; issues related to greenhouse gas emission policy; issues related to budget and reconciliation; issues related to tariff policy; issues related to the Congressional Review Act (CRA) resolutions targeting California Clean Air Act waivers and related vehicle emissions standards; S. 1379, REPAIR Act
Draft age verification legislation; S.1586/H.R.1349 - App Store Accountability Act
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Freedom to Heal Act (H.R.6434/S.3346)
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Breakthrough Therapies Act (H.R.1393/S.689), psychedelics research and treatment policy, in general.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
STATES 2.0 Act
Client: COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Breakthrough Therapies Act (H.R.1393/S.689), psychedelics research and treatment policy, in general.
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Client: REASON FOR HOPE · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Issues related to aircraft procurement, cUAS, and military logistics
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
VETERAN MENTAL HEALTH LEADERSHIP COALITION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Freedom to Heal Act (H.R.6434/S.3346)
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Freedom to Heal Act (H.R.6434/S.3346)
Veterans mental health research & treatment
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RECONVIEW, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Federal property security & public safety
Filing targets: Air Force, Dept of, Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE
PALL CORPORATION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to filtration, separation, and purification technologies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
H.R.7024/S.3686, Hemp Planting Predictability Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access.
Age verification legislation, H.R. 3149, App Store Accountability Act.
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; issues related to seasonal influenza vaccine development framework.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PALL CORPORATION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · RR
Issues related to filtration, separation, and purification technologies.
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation, H.R. 3149, App Store Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
RECONVIEW, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Federal property security & public safety
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
H.R.7024/S.3686, Hemp Planting Predictability Act
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VETERAN MENTAL HEALTH LEADERSHIP COALITION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Freedom to Heal Act (H.R.6434/S.3346)
Veterans mental health research & treatment
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Issues related to aircraft procurement, cUAS, and military logistics
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Research, development, and reimbursement of novel serotonergic agonists for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to aircraft procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VETERAN MENTAL HEALTH LEADERSHIP COALITION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Research, development, and reimbursement of novel serotonergic agonists for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to funding for psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RECONVIEW, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Federal property security & public safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
Age verification legislation, H.R. 3149, App Store Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
H.R.7024/S.3686, Hemp Planting Predictability Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
RECONVIEW, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Federal property security & public safety
VETERAN MENTAL HEALTH LEADERSHIP COALITION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Freedom to Heal Act (H.R.6434/S.3346) & federal funding for psychedelic medicine research
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Research, development, and reimbursement of novel serotonergic agonists for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Issues related to psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Issues related to aircraft procurement; issues related to impact of tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Issues related to H.R. 1 implementation and government contracting
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CARLYLE INVESTMENT MANAGEMENT LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to private equity firms and BDC reporting requirements
ANTOFAGASTA MINERALS S.A. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · 1@
Mining opportunities in northeast Minnesota
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to broadband; issues related to spectrum auction authority; issues related to privacy legislation issues related to utility pole access; issues related to AI policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to aircraft procurement; issues related to impact of tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Research, development, and reimbursement of psychedelics for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to psychedelics research and psychedelic-assisted therapy
Veterans mental health research & treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
EPA permitting timelines; H.R.4880/S.2505, Primacy Certainty Act of 2025
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Carbon capture facility deployment, development, and incentives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Draft age verification legislation; S.1586/H.R.1349 - App Store Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to H.R. 1 implementation and government contracting
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · RR
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
COMCAST CORPORATION via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to broadband; issues related to spectrum auction authority; issues related to privacy legislation; issues related to tax policy; issues related to budget and reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOYOTA MOTOR NORTH AMERICA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to the implementation of the Inflation Reduction Act; issues related to tax policy; issues related to privacy policy; issues related to greenhouse gas emission policy; issues related to budget and reconciliation; issues related to tariff policy; issues related to the Congressional Review Act (CRA) resolutions targeting California Clean Air Act waivers and related vehicle emissions standards; S. 1379, REPAIR Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to aircraft procurement
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Carbon capture facility deployment, development, and incentives
EPA permitting timelines; Primacy Certainty Act
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act; H.R.1, Enhancing Energy Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Cannabis legalization and regulation; H.R. 2934- STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES
CARLYLE INVESTMENT MANAGEMENT LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Investments in 401K plans.
Filing targets: Labor, Dept of (DOL)
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Issues related to aircraft procurement
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Carbon capture facility deployment, development, and incentives
EPA permitting timelines; Primacy Certainty Act
45Q Tax Credit; S.425/H.R.1003 - Enhancing Energy Recovery Act
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ANTOFAGASTA MINERALS S.A. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · 1T
Mining opportunities in northeast Minnesota
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Age verification legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Research, development, and reimbursement of psychedelics for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Issues related to psychedelics research and psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Research, development, and reimbursement of psychedelics for mental health conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Carbon capture incentives
EPA permitting timelines
Carbon capture facility deployment, development, and incentives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMBRAER AIRCRAFT HOLDING, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Issues related to aircraft procurement
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
PEPFAR funding; IVF and surrogacy access for same sex couples; PrEP and HIV test kit access; and international human rights as it relates to the LGBTQ+ community.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTOFAGASTA MINERALS S.A. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Mining opportunities in northeast Minnesota
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Carbon capture facility deployment, development, and incentives
Carbon capture incentives
EPA permitting timelines
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
PEPFAR funding; IVF and surrogacy access for same sex couples; PrEP and HIV test kit access; and international human rights as it relates to the LGBTQ+ community.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ANTOFAGASTA MINERALS S.A. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Mining opportunities in northeast Minnesota
Filing targets: HOUSE OF REPRESENTATIVES
OTSUKA AMERICA PHARMACEUTICAL, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · RR
Research, development, and reimbursement of novel mental health treatments
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · RR
HIV prevention; LGTBQ family formation challenges including surrogacy and IVF
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ANTOFAGASTA MINERALS S.A. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Mining opportunities in northeast Minnesota
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Carbon capture facility deployment, development, and incentives
Carbon capture incentives
EPA permitting timelines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEIMDAL, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · RR
Carbon capture facility deployment, development, and incentives
Carbon capture facility deployment, development, and incentives
Carbon capture facility deployment, development, and incentives
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LITE RUN via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Issues related to funding and procurement of mobility devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REASON FOR HOPE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Breakthrough Therapies Act (H.R.1393/S.689), psychedelics research and treatment policy, in general.
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION (CPEAR) via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Cannabis legalization and responsible regulation.
ANTOFAGASTA MINERALS S.A. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Issues related to the development of the Twin Metals Mine in Minnesota.
Issues related to the development of the Twin Metals Mine in Minnesota.